跳到正文
原文
Eric Topol· @EricTopol · X·· 10 天前AI 评分38
AI 导读

这是否可能成为动脉粥样硬化一级预防的未来策略? 体内CRISPR碱基编辑ANGPLT3基因,实现显著且持久的降脂效果。 在实验模型(包括非人灵长类)中获得有前景的数据,正推进至临床试验 @Nature https://www.nature.com/articles/s41586-026-11233-9

正文

Is this a potential future strategy for primary prevention of atherosclerosis?
CRISPR base editing in vivo of the ANGPLT3 gene to achieve marked and durable lipid lowering.
Promising data in experimental models, including hon-human primates, moving on to clinical trials
@Nature https://www.nature.com/articles/s41586-026-11233-9

来源:Eric Topol · x.com